In This Article:
Gallman’s Appointment is Effective Immediately
Sandra Leung, Executive Vice President, General Counsel Retires After 33 Years of Service
PRINCETON, N.J., May 06, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the appointment of Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer, effective immediately. Gallman succeeds Sandra (Sandy) Leung, who has chosen to retire after an extraordinary 33-year career at the company.
Gallman, an accomplished leader with extensive experience in pharmaceutical law and compliance, will lead the law department, which includes intellectual property, commercial and regulatory law, litigation, securities and corporate governance, transactions, corporate security and compliance and ethics, as well as global and U.S. policy and government affairs. She has held leadership positions at Bristol Myers Squibb for 10 years, most recently serving as Executive Vice President, Corporate Affairs.
"Cari brings a unique combination of legal, policy and communications expertise, coupled with an impressive ability to inspire teams, uphold ethical business practices and champion patient voices," said Christopher Boerner, Ph.D., board chair and chief executive officer, Bristol Myers Squibb. "I am confident that under Cari’s leadership, our legal and policy teams are well positioned to advance Bristol Myers Squibb’s efforts to drive and deliver innovation to patients facing serious diseases."
"It is an honor to have the opportunity to lead the incredible teams that govern and counsel Bristol Myers Squibb in advancing its mission to deliver transformational medicines to more patients," said Gallman. "I am committed to continuing to build on the company’s culture of integrity and shape a dynamic policy environment that protects innovation and patients."
On Sandy’s retirement, Boerner said, "Sandy’s resilience, steadfast leadership, and unwavering commitment to patients have left an indelible mark on our company. On behalf of the entire organization, I want to express our deepest gratitude to Sandy for her decades of service and wish her all the best in her well-deserved retirement."
About Cari Gallman
Prior to her appointment as Bristol Myers Squibb’s Executive Vice President, General Counsel and Chief Policy Officer, Cari Gallman served as Executive Vice President, Corporate Affairs and was responsible for advancing the company strategy through strategic communications, government relations and policy, corporate social responsibility, corporate marketing and brand reputation, and patient advocacy.